Bain Capital Life Sciences Investors, LLC - Insider Trading & Ownership

Location
200 Clarendon Street, Boston, MA
Summary
The estimated value of insider holdings of Bain Capital Life Sciences Investors, LLC is at least $735M dollars as of August 13, 2025. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $239M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $201M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Heartflow, Inc. and owns shares of Heartflow, Inc. (HTFL) stock worth about $189M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $46.3M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Olema Pharmaceuticals, Inc. and owns shares of Olema Pharmaceuticals, Inc. (OLMA) stock worth about $24.8M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Annexon, Inc. and owns shares of Annexon, Inc. (ANNX) stock worth about $24.4M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of RAPID MICRO BIOSYSTEMS, INC. and owns shares of RAPID MICRO BIOSYSTEMS, INC. (RPID) stock worth about $8.35M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $2.33M.
Signature
See signatures included in Exhibit 99.1
All Insider Reports
All Insider Reports

Ownership of Bain Capital Life Sciences Investors, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NAMS, NAMSW NewAmsterdam Pharma Co N.V. 10%+ Owner $239M +$40M +20.1% Dec 13, 2024
SWTX SpringWorks Therapeutics, Inc. 10%+ Owner $201M Aug 10, 2021
HTFL Heartflow, Inc. 10%+ Owner $189M Aug 11, 2025
SLDB Solid Biosciences Inc. 10%+ Owner $46.3M +$30M +184% Feb 19, 2025
OLMA Olema Pharmaceuticals, Inc. 10%+ Owner $24.8M +$1.73M +7.5% Jan 8, 2025
ANNX Annexon, Inc. 10%+ Owner $24.4M May 25, 2023
RPID RAPID MICRO BIOSYSTEMS, INC. 10%+ Owner $8.35M Jul 19, 2021
XLO Xilio Therapeutics, Inc. 10%+ Owner $2.33M Dec 8, 2021
KYTX Kyverna Therapeutics, Inc. 10%+ Owner Feb 12, 2024

Insider Transactions Reported by Bain Capital Life Sciences Investors, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.